Insider trades

Stengone Carmine N.

Stengone Carmine N. made 0 buys and 4 sales on the open market in the last 12 months at Contineum Therapeutics, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Contineum Therapeutics, Inc.
NASDAQ:CTNM
Director, CEO and President17,217Sep 8, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Contineum Therapeutics, Inc.
NASDAQ:CTNM
Sep 8, 2026Sale2,500US$16.46US$41,15017,217Sep 8, 2026
Contineum Therapeutics, Inc.
NASDAQ:CTNM
Aug 3, 2026Sale2,500US$16.01US$40,02517,217Aug 3, 2026
Contineum Therapeutics, Inc.
NASDAQ:CTNM
Jul 8, 2026Sale2,500US$16.00US$40,00017,217Jul 8, 2026
Contineum Therapeutics, Inc.
NASDAQ:CTNM
Jun 30, 2026Sale10,000US$16.01US$160K17,217Jul 1, 2026